Overview and implications of the drug patent-approval linkage system in South Korean Regulation | Practical Law
This article examines the drug patent-approval linkage system in South Korea and its implications. The system prohibits the sale of generic drugs which would infringe the patents of brand-name pharmaceutical companies who have developed the original drugs, by alerting the original patent holders and by withholding marketing approval. This has the object of protecting the rights of the patent holders.